Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 7 studies | 22% ± 5% | |
fibroblast | 7 studies | 20% ± 6% | |
plasmacytoid dendritic cell | 4 studies | 22% ± 3% | |
glutamatergic neuron | 3 studies | 19% ± 5% | |
myofibroblast cell | 3 studies | 17% ± 0% | |
epithelial cell | 3 studies | 38% ± 9% | |
dendritic cell | 3 studies | 24% ± 5% | |
basal cell | 3 studies | 25% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3049.93 | 1445 / 1445 | 100% | 52.34 | 183 / 183 |
liver | 100% | 2233.08 | 226 / 226 | 100% | 89.54 | 406 / 406 |
ovary | 100% | 4847.56 | 180 / 180 | 100% | 102.13 | 430 / 430 |
pancreas | 100% | 2099.04 | 328 / 328 | 100% | 87.22 | 178 / 178 |
prostate | 100% | 5006.71 | 245 / 245 | 100% | 111.21 | 502 / 502 |
skin | 100% | 2686.95 | 1809 / 1809 | 100% | 125.13 | 472 / 472 |
thymus | 100% | 6189.69 | 653 / 653 | 100% | 162.87 | 605 / 605 |
uterus | 100% | 4935.89 | 170 / 170 | 100% | 117.42 | 459 / 459 |
brain | 100% | 3311.45 | 2640 / 2642 | 100% | 155.90 | 705 / 705 |
lung | 100% | 3404.89 | 578 / 578 | 100% | 86.74 | 1154 / 1155 |
kidney | 100% | 3514.69 | 89 / 89 | 99% | 72.97 | 895 / 901 |
intestine | 100% | 3387.21 | 966 / 966 | 99% | 60.89 | 523 / 527 |
bladder | 100% | 3534.38 | 21 / 21 | 99% | 87.20 | 500 / 504 |
breast | 100% | 3315.45 | 459 / 459 | 99% | 85.02 | 1109 / 1118 |
adrenal gland | 100% | 3371.49 | 258 / 258 | 99% | 99.53 | 228 / 230 |
stomach | 100% | 2529.77 | 359 / 359 | 99% | 56.13 | 283 / 286 |
adipose | 100% | 2925.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3049.67 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 180.87 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 113.96 | 29 / 29 |
spleen | 100% | 3432.38 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 92.71 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 195.47 | 1 / 1 |
muscle | 99% | 1774.51 | 797 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1977.30 | 854 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 90% | 1331.21 | 833 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006338 | Biological process | chromatin remodeling |
GO_0016567 | Biological process | protein ubiquitination |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0009952 | Biological process | anterior/posterior pattern specification |
GO_0031519 | Cellular component | PcG protein complex |
GO_0016607 | Cellular component | nuclear speck |
GO_0001739 | Cellular component | sex chromatin |
GO_0000151 | Cellular component | ubiquitin ligase complex |
GO_0035102 | Cellular component | PRC1 complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0097027 | Molecular function | ubiquitin-protein transferase activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0003682 | Molecular function | chromatin binding |
Gene name | RING1 |
Protein name | E3 ubiquitin-protein ligase RING1 (EC 2.3.2.27) (Polycomb complex protein RING1) (RING finger protein 1) (RING-type E3 ubiquitin transferase RING1) (Really interesting new gene 1 protein) |
Synonyms | RNF1 RING1A |
Description | FUNCTION: Constitutes one of the E3 ubiquitin-protein ligases that mediate monoubiquitination of 'Lys-119' of histone H2A, thereby playing a central role in histone code and gene regulation. H2A 'Lys-119' ubiquitination gives a specific tag for epigenetic transcriptional repression and participates in X chromosome inactivation of female mammals. Essential component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1 complex acts via chromatin remodeling and modification of histones, rendering chromatin heritably changed in its expressibility. Compared to RNF2/RING2, it does not have the main E3 ubiquitin ligase activity on histone H2A, and it may rather act as a modulator of RNF2/RING2 activity. . |
Accessions | ENST00000383212.4 [Q06587-1] Q06587 ENST00000436128.2 [Q06587-1] ENST00000427374.2 [Q06587-1] ENST00000430233.2 [Q06587-1] ENST00000415941.2 [Q06587-1] ENST00000374656.5 [Q06587-1] |